Establishment Labs Holdings Inc. (ESTA) intrinsic value & 10-year financials

Establishment Labs Holdings Inc. (ESTA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 25.3% a year to $211.1M, with an average return on invested capital of -29.7%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$59.18
Market cap
$1.8B
Revenue (FY2025)
$211.1M
Revenue growth (10-yr CAGR)
25.3%
ROIC (10-yr avg)
-29.7%
Free cash flow (FY2025)
-$56.9M

ESTA 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $211.1M -$51.1M -$1.72 -$56.9M -18.5% -17.8%
FY2024 $166.0M -$84.6M -$3.00 -$64.6M -30.1% -28.0%
FY2023 $165.2M -$78.5M -$3.07 -$96.4M -39.4% -47.4%
FY2022 $161.7M -$75.2M -$3.08 -$55.0M -24.5% -51.1%
FY2021 $126.7M -$41.1M -$1.72 -$30.0M -19.8% -53.9%
FY2020 $84.7M -$38.1M -$1.63 -$14.9M -33.0% -60.5%
FY2019 $89.6M -$38.1M -$1.86 -$36.3M -34.5% -61.8%
FY2018 $61.2M -$21.1M — -$35.6M -39.0% -74.0%
FY2017 $34.7M -$34.9M — -$32.9M -57.6% 127.1%
FY2016 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

ESTABLISHMENT LABS HOLDINGS INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

ESTABLISHMENT LABS HOLDINGS INC. has historically struggled to out-earn its cost of capital, averaging just -45.8% ROIC.

ESTABLISHMENT LABS HOLDINGS INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, ESTABLISHMENT LABS HOLDINGS INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-57.13 per share.

ESTA stock: frequently asked questions

What is the intrinsic value of Establishment Labs Holdings Inc. (ESTA) stock?

Graham's formula only works with positive earnings. Establishment Labs Holdings Inc. reported diluted EPS of -$1.72 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Establishment Labs Holdings Inc. generate free cash flow?

Establishment Labs Holdings Inc. generated -$56.9M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 9 reported years.

What is ESTA's return on invested capital?

Average ROIC over the last 10 fiscal years was -29.7%, and average return on equity was -256.3%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ESTA data come from?

From Establishment Labs Holdings Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 7, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar orthopedic, prosthetic & surgical appliances & supplies stocks